Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs ...
Novo Nordisk (NVO) increased valuation gap with Eli Lilly (LLY) after its Phase 3 data for next-gen weight loss drug ...
Novo Nordisk could also post results for semaglutide, the active ingredient in Wegovy and Ozempic, in treating patients with Alzheimer's disease and metabolic dysfunction-associated steatohepatitis, ...
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
The president-elect made the announcement on Truth Social on Sunday. ABC News’ MaryAlice Parks discusses President Joe Biden's invitation for President-elect Donald Trump to visit the White ...
A tour company in Roatan has explained why the cruise port is still safe to visit despite the current Level 3 travel advisory. Symphony of the Seas’ next sailing will once again have to skip San ...